Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

INSANE: 4 - The Real Truth

First futures market for health care planned in Chicago

A group is seeking regulatory approval for the Intelligent Medicine Exchange, which could help participants hedge risks from rising medical costs.

Chicago Sun-Times

$100 Invested In CME Group 10 Years Ago Would Be Worth This Much

$100 Invested In CME Group 10 Years Ago Would Be Worth This Much

CME Group (NASDAQ:CME) has outperformed the market over the past 10 years by 2.35% on an annualized basis producing an average annual return of 14.45%. Currently, CME Group has a market capitalization of $71.41 billion.

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2022

Upgrades Credit Suisse upgraded the previous rating for Molecular Partners AG (NASDAQ:MOLN) from Underperform to Neutral. NoneAt the moment, the stock has a 52-week-high of $32.04 and a 52-week-low of $5.92. Molecular Partners closed at $6.88 at the end of the last trading period.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Analyst Ratings for CME Group

Over the past 3 months, 11 analysts have published their opinion on CME Group (NASDAQ:CME) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2022

Why are gas prices so high? These obscure traders are partly to blame

‘Nobody with power is looking at what they’re doing,’ but they’re helping to drive searing gas prices despite increased oil production

The Guardian - US

Recap: CME Group Q1 Earnings

CME Group (NASDAQ:CME) reported its Q1 earnings results on Wednesday, April 27, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

inkl

Read news from The Economist, FT, and more,
with one subscription

Where CME Group Stands With Analysts

Where CME Group Stands With Analysts

Over the past 3 months, 9 analysts have published their opinion on CME Group (NASDAQ:CME) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

What 8 Analyst Ratings Have To Say About CME Group

What 8 Analyst Ratings Have To Say About CME Group

CME Group (NASDAQ:CME) has observed the following analyst ratings within the last quarter:

ZoomInfo And 3 Other Stocks Sold By Insiders

ZoomInfo And 3 Other Stocks Sold By Insiders

Crude oil futures dropped around 3.5% on Tuesday, after reaching a new 7-year high level in the previous session. Investors, meanwhile, focused on some notable insider trades.

Where CME Group Stands With Analysts

Where CME Group Stands With Analysts

Analysts have provided the following ratings for CME Group (NASDAQ:CME) within the last quarter:

Recap: CME Group Q4 Earnings

Recap: CME Group Q4 Earnings

CME Group (NASDAQ:CME) reported its Q4 earnings results on Wednesday, February 9, 2022 at 07:00 AM. Here's what investors need to know about the announcement.

Expert Ratings For CME Group

Expert Ratings For CME Group

CME Group (NASDAQ:CME) has observed the following analyst ratings within the last quarter:

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

B of A Securities

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

382,806 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play